ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » Infectious Disease

Top Infectious Disease Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ALBERT COKER M>D>

Infectious Disease

9,306

$429K

428
333 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 38%

$46
Average prescription price

Avg: $251

MICHAEL SAAG MD

Infectious Disease

5,909

$2.35M

199
18 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 38%

$398
Average prescription price

Avg: $251

C BODET MD

Infectious Disease

4,567

$510K

275
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 38%

$112
Average prescription price

Avg: $251

PATRICK NOLAN MD

Infectious Disease

4,303

$501K

332
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 38%

$117
Average prescription price

Avg: $251

MUKESH PATEL MD

Infectious Disease

4,082

$338K

194
134 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 38%

$83
Average prescription price

Avg: $251

STEVEN ALSIP MD

Infectious Disease

4,059

$514K

266
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 38%

$127
Average prescription price

Avg: $251

KENNETH MIDDLEBROOKS M.D

Infectious Disease

3,729

$442K

215
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 38%

$118
Average prescription price

Avg: $251

SHIRIN BANU M.D

Infectious Disease

3,602

$174K

288
118 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 38%

$48
Average prescription price

Avg: $251

SHANNON TYLER MD

Infectious Disease

3,073

$1.81M

175
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

64%
prescriptions for brand name drugs

Avg: 38%

$590
Average prescription price

Avg: $251

BRUCE TUCKER M.D.

Infectious Disease

2,957

$322K

163
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 38%

$109
Average prescription price

Avg: $251

APRIL TRUETT M.D.

Infectious Disease

2,593

$1.28M

97
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 38%

$493
Average prescription price

Avg: $251

BARBARA HANNA M.D.

Infectious Disease

2,132

$1.19M

104
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

63%
prescriptions for brand name drugs

Avg: 38%

$557
Average prescription price

Avg: $251

WICKLIFFE MANY M.D.

Infectious Disease

1,796

$856K

100
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 38%

$476
Average prescription price

Avg: $251

RICARDO MALDONADO MD

Infectious Disease

1,633

$863K

154
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 38%

$528
Average prescription price

Avg: $251

DAVID BARNES M.D.

Infectious Disease

1,541

$154K

143
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 38%

$100
Average prescription price

Avg: $251

PATRICK HARRIS M.D.

Infectious Disease

1,467

$391K

116
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 38%

$267
Average prescription price

Avg: $251

MICHAEL MUGAVERO MD

Infectious Disease

1,292

$512K

82
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 38%

$396
Average prescription price

Avg: $251

PAUL GOEPFERT MD

Infectious Disease

1,260

$427K

67
0 are 65+

18%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 38%

$339
Average prescription price

Avg: $251

RICHARD SPERA MD

Infectious Disease

1,220

$282K

100
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 38%

$231
Average prescription price

Avg: $251

HAFSA SIDDIQUI M.D.

Infectious Disease

1,159

$288K

150
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 38%

$249
Average prescription price

Avg: $251

CRAIG HOESLEY MD

Infectious Disease

1,139

$428K

73
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 38%

$376
Average prescription price

Avg: $251

JAMES WILLIG MD

Infectious Disease

1,127

$420K

61
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 38%

$372
Average prescription price

Avg: $251

DENNIS DELGADO MD

Infectious Disease

1,098

$255K

188
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 38%

$232
Average prescription price

Avg: $251

SONYA HEATH MD

Infectious Disease

1,077

$399K

93
11 are 65+

25%
patients receiving schedule two controlled substances

Avg: 2%

25%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 38%

$370
Average prescription price

Avg: $251

ASHOK JAGANI MD

Infectious Disease

1,052

$103K

86
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 38%

$98
Average prescription price

Avg: $251

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank